Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1054_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
23 Мб
Скачать
250
https://t.me/medicina_free
Picture 31.3 Final result of submuscular implants
I. Kasana
Seroma It is relatively uncommon with submus-
cular implants after drain removal. It is safer to leave small seromas alone as it gets reabsorbed by 4weeks. Large uncomfortable uid collection need drainage under ultrasound guidance to pre­vent puncturing of implant with strict aseptic precautions.
Infection Infection usually happens by the end
of the third week. Common organisms are staph­ylococci and pseudomonas. Longer course of antibiotics is usually required.
In case of non-response to antibiotics implant loss is inevitable. Various implant salvage tech­niques are used to prevent the loss of implant. In our centre we remove the implant and ll the cav­ity with distilled water mixed with antibiotics and re-insert the implant after 48–72h under antibiot­ics cover. For implant infection we use combina­tion of teicoplanin and gentamycin till culture is available.
Upward Migration of Implant Happens in most cases of submuscular implant reconstruc­tion and need to be factored in at the time of oper­ation or symmetrisation surgery. In some cases, revision surgery and lowering of implant is require.
Other Complications Red breast syndrome, capsular contracture, implant deation (saline leakage), implant migration, implant ip over, port ip over, pain (capsule contracture is com­mon cause), rupture, nipple sensation changes, implant extrusion, chronic pain, and radiotherapy related severe contracture and scarring.
31.2 Subpectoral Implant Using Mesh (Synthetic or Biological)
The introduction of biological and synthetic meshes in the early 2000s to augment the sub­muscular pocket has had a major impact on the practice of immediate breast reconstruction. The mesh can be used as a sling between the lower edge of the pectoralis muscle and the IMF to pro­vide coverage for the lower pole of the implant. This creates a much bigger submuscular pocket and enables a single stage procedure with the desired size permanent implant placed at the time of mastectomy. With the use of meshes cosmetic outcomes are improved because of better lower pole projection and improved control of the infra­mammary fold, which creates a more natural looking shape. A wide range of biological (e.g., acellular dermal matrix) and synthetic (e.g., tita-
31 Two-Staged andSubpectoral Implant Breast Reconstruction
https://t.me/medicina_free
251
nium coated polypropylene) meshes are available in the market.
31.2.1 Indications
One-stage reconstruction for small to medium sized non-ptotic breasts. For large ptotic breasts reconstruction, lower pole is better supported with dermal sling covered elsewhere in this book. Previous radiotherapy and smokers have higher risk of complications and implant loss rate.
Patient Selection Most patients are suitable except very obese. In very obese patents it is dif­cult to get desired projection of implant beyond body’s thick skin and subcutaneous tissue. This leads to at looking reconstruction despite using implants with highest projection.
31.2.2 Preoperative Marking
The extent of breast is marked with dotted line. Inframammary fold is marked. Both options of nipple sparing (NSM) and skin sparing (SSM) are available. My preference is to remove nipple if the cancer is close to nipple, otherwise nipple is preserved but biopsy of the tissue from under­neath the nipple is taken to ensure clear margins.
Drain is placed in subcutaneous pocket. Skin is closed watertight in two layers. Steri-strips and waterproof dressing.
31.2.4 Implant Selection
Expander implants or implants can be used. Size of the implant is selected based on height and width of breast foot plate measured preopera­tively and size of pocket measured intraopera­tively. Weight of breast removed dictates volume of implant.
31.2.5 After Care
Single redivac drain. Antibiotics till drain in situ, usually 5–7days (Picture 31.4).
31.2.6 Complications
Bleeding Peri-implant haematoma is rare, in
most cases it does not need any intervention and is managed conservatively. Large or expanding haematoma will need washout under GA.
Flap Necrosis It is rare and happens in smokers and diabetics. Debridement and watertight clo­sure is necessary to avoid infection and implant loss.
31.2.3 Surgical Technique
Skin sparing mastectomy/NSM is done taking care not to disturb IMF. Pectoralis muscle is lifted along its lateral border to 3 ‘O’ clock or 9 ‘O’ clock in right and left breasts, respectively. Pectoralis major is lifted up to pre-marked extent of breasts. Some of the inner strong medial bres of pectoralis are divided to prevent implant being pushed laterally. ADM is cut to D-shape. Rounded side of the ADM is xed to Scarpa’s fascia at IMF with PDS sutures. Implant is placed in the pocket covered by muscle at the top and ADM below. Freed edge of the muscle is stitched to upper free edge of ADM to cover the implant.
Picture 31.4 ADM, nal result
252
https://t.me/medicina_free
I. Kasana
Seroma It is quite common after drain removal.
It is safer to leave it alone as it gets reabsorbed by 4 weeks. Large uncomfortable uid collection need drainage under ultrasound guidance to pre­vent puncturing of implant with strict aseptic precautions.
Infection Infection usually happens by the end
of the third week. Common organisms are staph­ylococci and pseudomonas. Longer course of antibiotics is usually required. In case of non­response to antibiotics implant loss is inevitable. Salvage can be done as explained in the previous section.
Upward Migration of Implant Happens in most cases of implant reconstruction and need to be factored in at the time of operation or symme­trisation surgery. In some cases, revision surgery and lowering of implant is require.
Other Complications Red breast syndrome, capsular contracture, implant deation (saline leakage), implant migration, implant ip over, port ip over, pain (capsule contracture is com­mon cause), rupture, nipple sensation changes, rippling (fat grafting can correct rippling), implant extrusion, chronic pain, and radiotherapy related severe contracture and scarring.
31.2.7 Conclusion
There are few options of implant reconstruction. Choice is made between these based on cost, availability of meshes, surgeon’s expertise, cos­mesis, and post-op pain and recovery. Two-stage submuscular implant is becoming obsolete now due to inferior cosmesis, two operations involved and postoperative pain and discomfort but is still a decent option where expensive meshes are not available or not affordable.
Subpectoral implant with meshes or total pre­pectoral reconstruction is debatable. Most sur­geons in UK have shifted to pre-pectoral implant reconstruction with ADM which is a quick and easy operation but is most expensive option of all (mesh costs ~£2000), nonetheless with less post­operative pain. The disadvantage is rippling and rapid take-off at the top and is not suitable for very slim patients.
Subpectoral implant is comparatively cheaper (mesh costs~£800) and gives smoother take-off at the top but more painful in the immediate post­operative period due to partial detachment of the muscle. This is better option than pre-pectoral implants in slim patients.
References
1. National Mastectomy and Breast Reconstruction
Audit. NHS Information centre. 48 page document.
2. Strock LL. Two-stage expander implant recon-
struction: recent experience. Plast Recontr Surg.
2009;124(5):1–7.
3. Spear SL, Pelletire CV.Immediate breast reconstruc-
tion in two stages using textured integrated-valve tis-
sue expanders and breast implants. Plastic Recons
Surg. 2004;113:2098–113.
4. Salgarello M, Seccia A, Eugenio F.Immediate breast
reconstruction with anatomical permanent expand-
able implants after skin sparing mastectomy: aes-
thetic and technical renements. Ann Plast Surg.
2004;52:358.
5. Roostaeian J, Pavone L, Da Lio A, etal. Immediate
placement of implants in breast reconstruction:
patient selection and outcomes. Plast Reconstr Surg.
2011;127(4):1407–16.
6. Scott L. Spear. Surgery of the breast, 3rd ed., vol. 1,
Chapter 30–37.
7. Mehrara BJ, Ho AY.Breast reconstruction. In: Harris
JR, Lippman ME, Morrow M, Osborne CK, editors.
Diseases of the breast. 5th ed. Philadelphia: Wolters
Kluwer Health; 2014.
8. Cutress RI, Summerhayes C, Rainsbury R.Guidelines
for oncoplastic breast reconstruction Breast recon-
struction. Oncoplastic Surg. 2013 April;95(3):161–2.
Thoraco-Abdominal Flap forLarge
https://t.me/medicina_free
Post-Mastectomy Defects inLocally Advanced Breast Cancer
S.V.S.Deo, ManojGowda, andJyotishmanSaikia
32
32.1 Learning Areas
• Applied anatomy of a thoracoabdominal (TA) ap
• Patient selection for TA ap
• Advantages of constructing a TA Flap
• Complications of TA ap
32.2 Introduction
Breast cancer is the most common malignancy globally and the leading cause of cancer death among women. The ratio of early breast cancer (EBC) to locally advanced breast cancer (LABC) is 1:9in developed countries, whereas it is 1:1in developing countries like India. Many times, these patients can present with large fun­gating masses, bleeding tumors, extensive skin involvement, and sometimes with chest wall inltration. These patients need radical surgical excision of soft tissues and involved skin to achieve a R-0 status, resulting in large post­mastectomy soft tissue defect not amenable for primary closure. The primary aim in such sce­narios is to offer a simple and reliable surgical technique to facilitate early wound healing and timely institution of adjuvant therapies. In addi-
S. V. S. Deo (*) · M. Gowda · J. Saikia Department of Surgical Oncology, DR BRAIRCH, All India Institute of Medical Sciences, New Delhi, India
tion, the surgical option should be simple enough to be carried out by a large number of surgeons in developing countries dealing with a high volume of LABC [1].
32.3 Surgical Anatomy ofTA Flap
Blood supply of the anterior wall of abdomen is provided by complex-interconnected vascular components that contribute blood supply to the adjacent muscles and skin [2]. The viability of the abdominal skin is based upon: The perforat­ing trunks and subdermal plexus. The perforating arteries are responsible for the origin of the blood supply. Knowledge of their locations and distri­bution is the most important element for the suc­cess of a local ap [3]. The subdermal plexus is comprised of an intricate network of micro­vessels dispersed throughout the skin of the abdomen and thorax, which distributes the blood supplied by the perforating arteries over an exten­sive skin surface. There are three perforating branch systems that guarantee the irrigation of the thoracic and abdominal wall: the epigastric system, the anterolateral intercostal system, and the groin system (Fig. 32.1). Thus, the most important aspect in designing a local ap is understanding the distribution of the perforating arteries, which allows for ap planning, manipu­lation during surgery and viability in the postop­erative period [4].
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023 S. V. S. Deo (ed.), Breast Oncoplasty and Reconstruction,
https://doi.org/10.1007/978-981-99-5536-7_32
253
254
https://t.me/medicina_free
S. V. S. Deo et al.
Fig. 32.1 Anatomical distribution of the perforating branches of the epigastric, groin, and intercostal posterior system
The TA ap utilizes the skin and subcutaneous
tissue of the anterior abdominal wall and is a rotation advancement fasciocutaneous ap (Type-c). It is based on two sets of direct perfo­rating segmental arteries arising from the subcostal, lumbar, and deep epigastric pedicles (Fig. 32.1). There are two sets of perforating
lateral side of the chest wall and axilla, a medially- based ap based on the medial perforat­ing branches should be used, whereas for medial soft tissue defects of chest wall, a laterally-based ap based on the lateral perforators should be uti­lized [6]. The vascular territory of the skin which
can be used in TA Flap is shown in Fig.32.2. branches— the lateral, arising from lumbar and subcostal arteries at the level of the anterior bor­der of the latissimus dorsi, and the medial, arising
32.3.1 Patient Selection forTA Flap
from the deep epigastric arcade at the lateral bor­der of the rectus abdominis [5]. Sub-facial anas­tomosis is present between the medial and lateral perforators. For post-mastectomy defects on the
Following factors can guide selection of patients
needing radical surgical excision of soft tissues
and involved skin to achieve a R-0 status:
32 Thoraco-Abdominal Flap forLarge Post-Mastectomy Defects inLocally Advanced Breast Cancer
https://t.me/medicina_free
maintaining a strict length–breadth ratio of 1:1 within the vascular territory as described above.
2. The limits of the ap are:
(a) Medial: Midline
(b) Lateral: Anterior axillary line
(c) Inferior: a horizontal plane at the level of
anterior superior iliac spine.
3. The plane of dissection should be maintained supercial to the rectus fascia and aponeuro­sis of the external oblique muscle.
4. The dissected ap can be advanced and rotated into the defect without tension (Figs.32.3 and 32.4).
5. The tip of the ap is trimmed in patients with doubtful viability and the wound closed using 2–0 nylon interrupted sutures after placing two closed suction drains one draining the mastectomy site and the other draining the donor area.
6. The lax abdominal skin can be adequately mobilized to effect primary closure of the donor site.
255
Fig. 32.2 Vascular territory of the area of skin and subcu­taneous tissue that can be utilized for thoraco-abdominal (TA) ap (dotted area)
• Tumor factors: – large fungating masses, – bleeding tumors, – extensive skin involvement, and – additional chest wall inltration
• Patient factors: – previous abdominal incisions – laxity of the abdominal wall
32.3.2 Surgical Steps
1. After completion of the mastectomy and
assessing the defect, the TA ap is marked,
32.3.3 Advantages ofTA Flap over Other Flaps andSSG
1. Simple, reliable, and cost-effective
procedure,
2. Easy to learn and apply in daily practice,
3. No donor site morbidly,
4. Less chance of ap loss,
5. Well tolerated by patients,
6. Can undergo adjuvant treatment without
delay.
32.3.4 Complications
1. Supercial Flap necrosis: The tip of the ap
may sometimes undergo necrosis, which should be managed by debridement and sec­ondary suturing or SSG.
256
cd
https://t.me/medicina_free
S. V. S. Deo et al.
a
b
Fig. 32.3 (a)-post-radical mastectomy defect, (b) -Lateral-based TA Flap, (c)-TA ap covering post-mastectomy defect, (d)-Donor site closure
2. SSI: Wound infections can occur when cover­ing defects after mastectomy for fungating and infected tumors. These can be managed by using antibiotics. A ve-day course of Amoxicillin–Clavulanic acid should be
3. Major ap loss: If planned properly, the chance of major ap loss is very less. In such cases antibiotic coverage and repeated debridement followed by SSG or LD ap should be planned.
enough to treat this condition.
32 Thoraco-Abdominal Flap forLarge Post-Mastectomy Defects inLocally Advanced Breast Cancer
https://t.me/medicina_free
257
Fig. 32.4 Medially based TA ap to cover the post-mastectomy defect
32.4 Conclusion
TA ap is a simple, reliable, and cost-effective procedure for managing large postmastectomy soft tissue defects in a subset of LABC. It has huge potential in developing countries dealing with a large number of LABC patients because of simplicity and short learning curve.
References
1. Leinster SJ, Webster DJ.Thoraco-abdominal and tho-
racoepigastric aps: alternatives to skin grafting after mastectomy. Clin Oncol. 1982 June;8(2):145–8.
2. Suryanarayana Deo SV, Mishra A, Shukla NK,
Sandeep B.Thoracoabdominal ap: a simple ap for covering large post-mastectomy soft tissue defects inlocally advanced breast cancer. Indian J Surg Oncol. 2019 Sep;10(3):494–498. doi: https://doi.org/10.1007/
258
https://t.me/medicina_free
S. V. S. Deo et al.
s13193- 019- 00927- 4. Epub 2019 May 2. PMID:
31496598; PMCID: PMC6707995.
3. Deo SS, Purkayastha J, Shukla NK, Asthana S.Myocutaneous versus thoraco-abdominal ap cover for soft tissue defects following surgery for locally advanced and recurrent breast cancer. J Surg Oncol. 2003;83:31–5. https://doi.org/10.1002/jso.10236.
4. Brown RG, Vasconez LO, Jurkiewicz MJ.Transverse abdominal aps and the deep epigastric arcade. Plast Reconstr Surg. 1975 Apr;55(4):416–21.
5. Bohmert H. Experience in breast reconstruction with thoraco-epigastric and advancement aps. Acta Chir Belg. 1980 Mar-Apr;79(2):105–10.
6. Parkash S, Srinivasan R, Ananthakrishnan N.Primary closure of excisional defects of the breast with local aps: a problem in the treatment of advanced car­cinoma of the breast in developing countries. Br J Plast Surg. 1981 July;34(3):291–4. https://doi.
org/10.1016/0007- 1226(81)90011- 4.
Oncoplastic Breast
https://t.me/medicina_free
Surgery- Common Complications andManagement
S.P.Somashekhar, ArchaPrasad, andSaiRamPillarisetti
33
33.1 Introduction
The goal of oncoplastic procedures is to resect the breast cancer with negative histological mar­gins while preserving the contour of the breast. Oncoplastic surgery merges the principles of oncology and reconstructive surgery, utilising a spectrum of aesthetic enhancing techniques to address tissue defects and optimise cosmesis from breast cancer surgery. The core of oncoplas­tic breast management exists in four disciplines— surgical oncology, plastic surgery, radiation oncology and medical oncology—and the tim­ing, efcacy and role of each modality consid­ered concomitantly often in a tumour board or multidisciplinary breast centre.
S. P. Somashekhar (*) MHEPL, Bengaluru, India
Manipal Comprehensive Cancer center, Manipal, India
Manipal University, Manipal, India
Breast Surgeon of India, Manipal Hospital, Bangalore, India
A. Prasad Manipal Comprehensive Cancer center, Manipal, India
Manipal University, Manipal, India
S. R. Pillarisetti University of Central Lancashire, Preston, UK
Oncoplastic breast surgery has traditionally
been a safe operation with low morbidity and mortality. Although the incidence of postopera­tive complications is low, physicians should be aware of the morbidity unique to it.
In one of the largest comprehensive literature
reviews to date on oncoplastic BCS. Outcome After Oncoplastic Breast-Conserving Surgery in Breast Cancer Patients by De La Cruz L, the sys­tematic review reveals high rates of OS and DFS with low LR, DR, PMR, RR, CMR and compli­cation rates. This chapter reviews the common complications encountered in these patients and the approaches for management and goals to anticipate and prevent adverse events and to accelerate recovery [1].
(Depending on Time of Event)
Immediate Late Long Term Bleeding Contour
deformity
Seroma/ Hematoma
Infection Volume loss Radiation
Delayed wound healing
Wound dehiscence Flap necrosis Chronic pain Pnemothorax Nipple areolar
Scar widening Fat necrosis
“Plugged in appearance
necrosis.
Local recurrence
brosis Flap
contracture
Breast asymmetry
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023 S. V. S. Deo (ed.), Breast Oncoplasty and Reconstruction,
https://doi.org/10.1007/978-981-99-5536-7_33
259